Dr. SCHEIR PETRA - Gynaecologie
0821.912.771 · rovalta.com · 26/09/2026
Dr. SCHEIR PETRA - Gynaecologie
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr. SCHEIR PETRA - Gynaecologie is a Private limited company incorporated in 2010. Its registered office is in Ronse.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0821.912.771
- Incorporation
- 04/01/2010
- Legal form
- Private limited company
- Registered office
- Hogerlucht 116C
9600 Ronse · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 10209
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 169,2 k € | +5.4% | 160,5 k € | +1.7% | 157,9 k € | -7.7% | 171 k € | +23.5% | 138,5 k € |
| EBITDA | 168,2 k € | +10.5% | 152,2 k € | -2.2% | 155,7 k € | -8.2% | 169,5 k € | +23.9% | 136,8 k € |
| Operating result | 154,8 k € | +7.4% | 144,2 k € | -6.3% | 153,8 k € | -7.6% | 166,4 k € | +24.7% | 133,5 k € |
| Net result | 113,7 k € | +8.5% | 104,8 k € | -3.1% | 108,1 k € | -2.4% | 110,7 k € | +19.3% | 92,8 k € |
| Balance sheet | |||||||||
| Equity | 659,8 k € | +10.8% | 595,4 k € | +12.8% | 527,8 k € | +6.9% | 493,6 k € | +28.9% | 382,9 k € |
| Total assets | 773,9 k € | +4.5% | 740,9 k € | +18.5% | 625 k € | +3.2% | 605,8 k € | +24.3% | 487,2 k € |
| Cash | 572 k € | +443% | 105,4 k € | -36.2% | 165,3 k € | -69.9% | 549,3 k € | +24.9% | 439,9 k € |
| Debts | 104,6 k € | -21.7% | 133,6 k € | +50.2% | 89 k € | -12.7% | 101,9 k € | +7.6% | 94,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 15/07/2026 | 07/07/2025 | 18/07/2024 | 11/08/2023 | 25/08/2022 | 26/07/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 09/07/2024 | 30/06/2023 | 16/08/2022 | 24/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 30/06/2026 | 15/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 07/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 09/07/2024 | 18/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 11/08/2023 | Dutch | |
| Micro model | 31/12/2021 | 16/08/2022 | 25/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 24/07/2021 | 26/07/2021 | Dutch | |
| Micro model | 31/12/2019 | 08/07/2020 | 24/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 29/06/2019 | 22/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 30/06/2018 | 06/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 26/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 06/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 27/06/2015 | 30/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 28/06/2014 | 25/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 22/06/2013 | 04/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 23/06/2012 | 09/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 25/06/2011 | 11/07/2011 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025113,7 k €↑
- 2024Annual accounts 2024104,8 k €↓
- 2023Annual accounts 2023108,1 k €↓
- 2022Annual accounts 2022110,7 k €↑
- 2021Annual accounts 202192,8 k €↑
- 2021Name changeDr. Scheir Petra - Gyneacologie BV
- 2020Annual accounts 202088,8 k €↑
- 2019Annual accounts 201949,3 k €↑
- 2018Annual accounts 201837,1 k €↓
- 2017Annual accounts 201738,9 k €↑
- 2016Annual accounts 201635 k €↓
- 2015Annual accounts 201553,4 k €↓
- 2014Annual accounts 201465,8 k €↑
- 2013Annual accounts 201352,2 k €↓
- 2012Annual accounts 201272,1 k €↑
- 2011Annual accounts 201127,1 k €↓
- 2010Annual accounts 201059,9 k €
- 04/01/2010IncorporationPrivate limited company
- 2010Name changeDr. SCHEIR PETRA - Gynaecologie